Qualitative study on decision-making by prostate cancer physicians during active surveillance

被引:25
|
作者
Loeb, Stacy [1 ,2 ,3 ,4 ]
Curnyn, Caitlin [2 ]
Fagerlin, Angela [5 ,6 ]
Braithwaite, Ronald Scott [2 ]
Schwartz, Mark D. [2 ,4 ]
Lepor, Herbert [1 ,3 ]
Carter, Herbert Ballentine [7 ]
Sedlander, Erica [2 ]
机构
[1] NYU, Dept Urol, New York, NY USA
[2] NYU, Dept Populat Hlth, New York, NY USA
[3] NYU, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA
[4] Manhattan Vet Affairs Med Ctr, New York, NY USA
[5] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA
[6] Informat Decis Enhancement & Surveillance IDEAS C, Salt Lake City, UT USA
[7] Johns Hopkins Univ Hosp, Brady Urol Inst, Baltimore, MD 21287 USA
关键词
prostate cancer; active surveillance; markers; qualitative; survey; MANAGEMENT; MEN; GUIDELINE;
D O I
10.1111/bju.13651
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To explore and identify factors that influence physicians' decisions while monitoring patients with prostate cancer on active surveillance (AS). Subjects and Methods A purposive sampling strategy was used to identify physicians treating prostate cancer from diverse clinical backgrounds and geographic areas across the USA. We conducted 24 in-depth interviews from July to December 2015, until thematic saturation was reached. The Applied Thematic Analysis framework was used to guide data collection and analysis. Interview transcripts were reviewed and coded independently by two researchers. Matrix analysis and NVIVO software were used for organization and further analysis. Results Eight key themes emerged to explain variation in AS monitoring: (i) physician comfort with AS; (ii) protocol selection; (iii) beliefs about the utility and quality of testing; (iv) years of experience and exposure to AS during training; (v) concerns about inflicting 'harm'; (vi) patient characteristics; (vii) patient preferences; and (viii) financial incentives. Conclusion These qualitative data reveal which factors influence physicians who manage patients on AS. There is tension between providing standardized care while also considering individual patients' needs and health status. Additional education on AS is needed during urology training and continuing medical education. Future research is needed to empirically understand whether any specific protocol is superior to tailored, individualized care.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [31] Mechanisms of decision-making in preoperative assessment for older adult prostate cancer patients-A qualitative study
    Kierkegaard, Patrick
    Vale, Mira D.
    Garrison, Spencer
    Hollenbeck, Brent K.
    Hollingsworth, John M.
    Owen-Smith, Jason
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 121 (03) : 561 - 569
  • [32] An exploration of wellbeing in men diagnosed with prostate cancer undergoing active surveillance: a qualitative study
    Omar Eymech
    Oliver Brunckhorst
    Louis Fox
    Anam Jawaid
    Mieke Van Hemelrijck
    Robert Stewart
    Prokar Dasgupta
    Kamran Ahmed
    Supportive Care in Cancer, 2022, 30 : 5459 - 5468
  • [33] An exploration of wellbeing in men diagnosed with prostate cancer undergoing active surveillance: a qualitative study
    Eymech, Omar
    Brunckhorst, Oliver
    Fox, Louis
    Jawaid, Anam
    Van Hemelrijck, Mieke
    Stewart, Robert
    Dasgupta, Prokar
    Ahmed, Kamran
    SUPPORTIVE CARE IN CANCER, 2022, 30 (06) : 5459 - 5468
  • [34] Active Surveillance for Prostate Cancer: A Systematic Review of the Literature
    Dall'Era, Marc A.
    Albertsen, Peter C.
    Bangma, Christopher
    Carroll, Peter R.
    Carter, H. Ballentine
    Cooperberg, Matthew R.
    Freedland, Stephen J.
    Klotz, Laurence H.
    Parker, Christopher
    Soloway, Mark S.
    EUROPEAN UROLOGY, 2012, 62 (06) : 976 - 983
  • [35] Active surveillance in intermediate risk prostate cancer: is it safe?
    Krishnananthan, Nishanth
    Lawrentschuk, Nathan
    INTERNATIONAL BRAZ J UROL, 2016, 42 (03): : 418 - 421
  • [36] Toward Ethically Responsible Choice Architecture in Prostate Cancer Treatment Decision-Making
    Blumenthal-Barby, J. S.
    Lee, Denise
    Volk, Robert J.
    CA-A CANCER JOURNAL FOR CLINICIANS, 2015, 65 (04) : 257 - 260
  • [37] Use of mpMRI in active surveillance for localized prostate cancer
    Scarpato, Kristen R.
    Barocas, Daniel A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (07) : 320 - 325
  • [38] Active surveillance for low-risk prostate cancer
    Bangma, Chris H.
    Bul, Meelan
    van der Kwast, Theo H.
    Pickles, Tom
    Korfage, Ida J.
    Hoeks, Caroline M.
    Steyerberg, Ewout W.
    Jenster, Guido
    Kattan, Michael W.
    Bellardita, Lara
    Carroll, Peter R.
    Denis, Louis J.
    Parker, Chris
    Roobol, Monique J.
    Emberton, Mark
    Klotz, Laurence H.
    Rannikko, Antti
    Kakehi, Yoshiyuki
    Lane, Janet A.
    Schroder, Fritz H.
    Semjonow, Axel
    Trock, Bruce J.
    Valdagni, Riccardo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (03) : 295 - 302
  • [39] Active surveillance for localized prostate cancer
    Staerman, F.
    Peyromaure, M.
    Irani, J.
    Gaschignard, N.
    Mottet, N.
    Soulie, M.
    Salomon, L.
    PROGRES EN UROLOGIE, 2011, 21 (07): : 448 - 454
  • [40] Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study
    Subramanian, Lalita
    Hawley, Sarah T.
    Skolarus, Ted A.
    Rankin, Aaron
    Fetters, Michael D.
    Witzke, Karla
    Chen, Jason
    Radhakrishnan, Archana
    CANCER MEDICINE, 2024, 13 (01):